- Home
- Clinical Trials
Zoster Vaccine Studies Kapiti ZOS
Shingles ZOSTER Vaccine Study
Kapiti
Are you 70 years or older and want to protect your health?
You may be eligible to join a clinical research study testing a new investigational vaccine for shingles (herpes zoster). The study is evaluating the tolerability and safety of the investigational vaccine and whether it can trigger an immune response.
By taking part, you may gain early access to potential new vaccine options, receive regular health checks, and contribute to medical research that could benefit thousands of people in the future.
Description
What to expect
Study details
Ages
70 years or older
Duration
Up to 16 months, and includes 8 scheduled clinic visits (2 for receiving the vaccine) and 7 telephone calls
Compensation
Participants will be compensated up to $900
Eligibility Criteria
You may qualify if you:
- Are 70 years or older
- Are in generally good health
- Have not previously received a shingles or chickenpox vaccine
- Have not caught shingles in the past
Other eligibility criteria apply. A member of our team will check if this study is a good fit for you.
Locations
Description
Shingles (Herpes Zoster) is a painful skin rash that may lead to complications such as long-lasting nerve pain, known as post-herpetic neuralgia (PHN). It is caused by the same virus that causes chickenpox – and it can reactivate later in life.
People 70 years of age and older are at higher risk for shingles and its complications. Although there is an approved vaccine, researchers are working to develop potential new options that may improve protection and reduce side effects.
This study is evaluating an investigational vaccine combining a viral protein with an immune-stimulating ingredient. Researchers are comparing the investigational vaccine to Shingrix (an existing and approved shingles vaccine) to see:
- How safe it is
- How well it stimulates the immune system
- Whether it helps prevent shingles and associated complications (i.e., PHN) in older adults
What to expect
Participants will be randomly assigned to receive:
- The investigational vaccine
- Shingrix (an approved shingles vaccine)
You will receive two vaccine doses and return for follow-up visits over the next year. The vaccine will be administered as an intramuscular injection.
After each vaccination, you’ll be given a symptom diary, a thermometer, and a small ruler. For 7 days after each dose, you will be asked to record any symptoms or reactions, such as redness or swelling at the injection site, fever, or general discomfort.
Our trained medical study team will closely monitor your health, track side effects, and take blood samples to measure immune response.
Why join this clinical research study?
- Gain early access to new potential vaccines at no cost
- Contribute to research that may benefit others like you
-Receive health checks and advice from our professional medical team
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.